Schedule 13G Filing for Merlin, Inc.

Bleichroeder Sponsor 1 LLC, Andrew Gundlach, and Michel Combes (collectively, the "Reporting Persons") have filed this Schedule 13G to report their beneficial ownership of Merlin, Inc. common stock. This filing amends a previous Schedule 13D filed on November 12, 2024, following the business combination between Merlin, Inc. (formerly Inflection Point Acquisition Corp. IV) and Merlin Labs, Inc. The Reporting Persons collectively own 8,800,833 shares, representing 10.4% of the outstanding common stock. This ownership was acquired through the conversion of rights and shares related to the business combination. Andrew Gundlach has resigned from his role as Executive Chairman of the board of directors. As the Reporting Persons no longer have board representation and do not beneficially own more than 20% of the common stock, and have not acquired the shares with the intent to change or influence control, they are filing this Schedule 13G under Rule 13d-1(c).